US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 72.520
  • -6.350-8.05%
Close Apr 18 16:00 ET
  • 72.520
  • 0.0000.00%
Post 16:20 ET
1.28BMarket Cap24.67P/E (TTM)

About Ligand Pharmaceuticals Company

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Company Profile

SymbolLGND
Company NameLigand Pharmaceuticals
Listing DateNov 17, 1992
Issue Price11.00
Founded1987
CEOMr. Todd C. Davis
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address555 Heritage Drive,Suite 200
CityJupiter
ProvinceFlorida
CountryUnited States of America
Zip Code33458
Phone1-858-550-7500
Websitehttp://www.ligand.com

Company Executives

  • Name
  • Position
  • Salary
  • Todd C. Davis
  • Chief Executive Officer and Director
  • 5.20M
  • Andrew Reardon
  • Chief Legal Officer and Secretary
  • 3.01M
  • Octavio Espinoza
  • Chief Financial Officer and Principal Accounting Officer
  • 3.27M
  • Matthew Korenberg
  • President and Chief Operating Officer
  • 6.54M
  • Dr. John W. Kozarich,PhD
  • Chairman of the Board
  • 586.60K
  • Dr. John L. LaMattina
  • Independent Director
  • 481.16K
  • Jason Haas
  • Independent Director
  • 490.57K
  • Dr. Stephen L. Sabba,M.D.
  • Independent Director
  • 571.60K
  • Dr. Nancy Ryan Gray, PhD
  • Independent Director
  • 436.41K
  • Martine Zimmermann
  • Independent Director
  • --
  • Jason M. Aryeh
  • Independent Director
  • 483.66K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg